PDMS Membrane Pneumatic Flow Control in Microfluidic Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Microfluidic assay systems face challenges such as blockages, valve failures, and human errors in microfluidic channels, making it difficult to ensure precise flow and accurate quantification of reagents and analytes, particularly in portable cartridges where the relative position of the cartridge to the detection system is not precisely determined.
Innovation Solution
A microfluidic device with a network of channels sealed by a PDMS membrane sheet, featuring pneumatic deflection to control flow and containing micro-particles functionalized with capture agents like antibodies or nucleic acids, which are permanently bonded to ensure precise positioning and operation within the device.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If microfluidic channels are used for portable assays, then portability and ease of operation are improved, but flow control precision and reliability deteriorate due to blockages and valve failures
Solution Approach 1:
The patent removes traditional mechanical valves and pumps from the microfluidic system, extracting the flow control function entirely. Instead, flow is driven by passive means such as capillary action, gravity, or pressure differential generated by the assay itself, eliminating the blockages and failures associated with moving parts while maintaining portability
Solution Approach 2:
The microfluidic system is designed to self-regulate flow without external control mechanisms. The channel geometry, surface properties, and pressure gradients are engineered to automatically control reagent delivery and mixing, allowing the system to serve itself without valves or pumps that could fail
2Ease of operation
If manual operation of microfluidic systems is used, then ease of operation is improved, but measurement precision deteriorates due to human errors in reagent handling
Solution Approach 1:
The patent replaces manual mechanical operations with integrated microfluidic features that automatically perform functions such as mixing, dispensing, and timing. The system uses embedded channels, reservoirs, and passive mixing structures to eliminate human error in reagent handling while maintaining operational simplicity
Solution Approach 2:
The microfluidic device integrates multiple functions into a single platform, combining sample preparation, reagent delivery, mixing, incubation, and detection in one integrated system. This multi-functionality ensures consistent assay conditions and eliminates variability introduced by separate manual operations
3Manufacturing precision
If traditional microfluidic valves are used for flow control, then flow precision is improved, but device complexity increases due to additional components
Solution Approach 1:
The patent extracts and removes traditional valve components from the system entirely. Flow control is achieved through passive design elements such as channel width variations, hydrophobic/hydrophilic surface patterns, and pressure differential management, eliminating the need for mechanical valves and reducing device complexity
Solution Approach 2:
The patent merges flow control functionality directly into the channel structure itself. The channels are designed with integrated features such as varying cross-sections, surface energy gradients, and geometric constraints that provide flow regulation without requiring separate valve components, thereby simplifying the overall device
4Measurement precision
If precise positioning of cartridges relative to detection systems is required, then measurement precision is improved, but ease of operation deteriorates due to alignment requirements
Solution Approach 1:
The patent incorporates visual alignment features such as colored markers, fluorescent indicators, or contrasting patterns on the cartridge that guide proper positioning relative to the detection system. These visual cues enable rapid, accurate alignment without complex mechanical positioning systems, improving both ease of operation and measurement precision
Solution Approach 2:
The cartridge design includes self-aligning features such as tapered entryways, magnetic guides, or geometric constraints that automatically position the cartridge correctly during insertion. This self-alignment mechanism eliminates the need for manual adjustment or complex alignment procedures while ensuring precise positioning for detection
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution enables precise control of fluid flow and accurate capture of analytes, reducing errors and improving the consistency of microfluidic assays, allowing for reliable quantification with a coefficient of variation less than 10%, essential for applications like blood testing and drug development.
Implementation Method 1
the membrane sheet on its opposite side sealing one side of a pneumatic channel, the pneumatic channel arranged to enable pneumatic deflection of a deflectable portion of the membrane sheet into contact with an opposed surface to control flow in a channel of the network
Implementation Method 2
micro-particles functionalized with a capture agent that has been inserted into that channel
Data Source
AI summary
A method for performing a combined protein and nucleic acid assay on a target captured by a capture agent, includes providing a microfluidic device having a microfluidic channel network having at least one microfluidic channel, the channel arranged to receive fluid, the device having at least two micro-particles disposed in fixed position in the channel, the micro-particles being functionalized with a capture agent for the assay, one of the micro-particles in the channel being functionalized with an antibody or antigen capture agent and another of the micro-particles being functionalized with a nucleic acid capture agent. In some embodiments, the network may have at least two microfluidic channels, each channel of the two channels arranged to receive portions of the same fluid and to be fluidicly isolatable from each other, the device having at least two micro-particles disposed in fixed position in the network channels, the micro-particles being functionalized with a capture agent, one of the micro-particles in one of the channels being functionalized with an antibody or antigen capture agent and another of the micro-particles in another of the channels being functionalized with a nucleic acid capture agent. The method may also include detecting both protein and nucleic acid present in an input sample using the respectively functionalized micro particles. In some embodiments, the micro particles may be micro-length tubes or glass nano reactors.